Label Changes for:
Reglan (metoclopramide) tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- September 2009
The goal of this REMS is to minimize the risk of tardive dyskinesia associated with the longterm use of Reglan tablets.
A Medication Guide will be dispensed with each Reglan tablet prescription.